In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair
about
Epigenetic changes of DNA repair genes in cancerMutS homologue hMSH5: role in cisplatin-induced DNA damage responseNo significant role for beta tubulin mutations and mismatch repair defects in ovarian cancer resistance to paclitaxel/cisplatinMSH2 is essential for the preservation of genome integrity and prevents homeologous recombination in the moss Physcomitrella patensPharmacologic resistance in colorectal cancer: a reviewSolution Structures of a DNA Dodecamer Duplex with and without a Cisplatin 1,2-d(GG) Intrastrand Cross-Link: Comparison with the Same DNA Duplex Containing an Oxaliplatin 1,2-d(GG) Intrastrand Cross-Link † , ‡Flanking Bases Influence the Nature of DNA Distortion by Platinum 1,2-Intrastrand (GG) Cross-LinksRole of Deficient Mismatch Repair in the Personalized Management of Colorectal CancerMismatch repair and treatment resistance in ovarian cancer.Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study.Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group.The role of mismatch repair in the prevention of base pair mutations in Saccharomyces cerevisiae.Sodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC)Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 yearsIntegrin αV modulates the cellular pharmacology of copper and cisplatin by regulating expression of the influx transporter CTR1.The "comparative growth assay": examining the interplay of anti-cancer agents with cells carrying single gene alterations.Drug therapy for hereditary cancersOn the discovery, biological effects, and use of Cisplatin and metallocenes in anticancer chemotherapyOngoing and unsaid on oxaliplatin: the hopeRole of mismatch repair proteins in the processing of cisplatin interstrand cross-links.Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cellsLoss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatinMismatch repair deficiency is associated with resistance to DNA minor groove alkylating agentsOxaliplatin-DNA adduct formation in white blood cells of cancer patientsMismatch repair deficiencies transforming stem cells into cancer stem cells and therapeutic implications.Epistatic role of base excision repair and mismatch repair pathways in mediating cisplatin cytotoxicityPhotoaffinity isolation and identification of proteins in cancer cell extracts that bind to platinum-modified DNA.Organic cation transporters are determinants of oxaliplatin cytotoxicity.Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells.Rapid DNA double-strand breaks resulting from processing of Cr-DNA cross-links by both MutS dimers.Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells.Better to be alone than in bad company: The antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer.Recognition of DNA alterations by the mismatch repair systemProgrammed death 1 blockade, an Achilles heel for MMR-deficient tumors?Molecular dynamic simulations of cisplatin- and oxaliplatin-d(GG) intrastand cross-links reveal differences in their conformational dynamicsThe effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells.
P2860
Q22242858-99941F66-9D68-4DF5-8C94-6FBB3EE8DA35Q24306821-A651BB81-BCD8-4F6D-97CF-2E590C1D05F5Q24531843-66899D70-F3B2-4D11-882D-89C1661597D2Q24535964-8A3ED834-C7EC-4BCA-99E9-7CF50A583102Q26769850-DE13FB86-D6EC-4E5E-AB7F-2E015E8613E4Q27644753-96C0B5E8-D592-4B45-82B2-41D506D7643CQ27671829-8EA95393-D603-4BBE-A487-ED35CB1B5604Q28080176-DB6B3EAF-D47A-41AA-B95E-5A446212D806Q33252378-A163268F-A162-46EE-A1EC-309C1A0472D5Q33378252-5EBB0DD7-562E-4D16-B1A2-7F22891D703DQ33383091-510C4385-6E00-41E1-A216-57914672EBF4Q33592366-D8D91A19-9883-4932-B60E-B53C6DBFF0ACQ33940195-A73589B9-1DAB-4A19-802B-13118CE4FB99Q34008793-4D07D85A-4527-4B3A-B0FD-6D6DAF2D9D3DQ34781192-7B32CBD9-8EA6-45B7-AE94-EE93F2DD96C3Q34786141-149A2F7F-F9A3-4E6B-B99B-D2D65CA825F5Q35208929-DD0E1DF6-7189-4096-97D5-671B75D59EB5Q36107216-1A6E364B-6E6B-45AC-BF77-8FF822745FABQ36291594-5BA02BC5-6BAB-445F-A984-DAD1F2C5626FQ36296744-79E8A1A6-4297-460D-8F7C-E64E98C1D2B0Q36617515-C872E839-EC06-4A11-B4C5-BB87B154D3A4Q36617626-E7B04453-422A-4985-851E-A6BC091B868EQ36617973-F52FB256-E38F-4B1E-BF97-9CC319328897Q36740632-E3B89E68-4568-47FC-B565-96169AC45C9FQ36779731-28C5ADBC-9337-4122-945F-550EC407F020Q37122036-96F8DBF6-2B83-4120-9D0C-6E540C07E6BAQ37261476-0F7950A9-76F1-440C-9C56-3EF1F79FA82BQ37416089-11FBF2B7-4E51-458B-BCE6-F3495C86B942Q38799295-79CF2447-0E03-4E39-9AA6-1587BC3EE0D5Q39464747-42D6B7BF-7F88-40F9-B0C5-D82C10267E6BQ39711077-24105343-D099-43C5-8CA8-5266D943F003Q41831075-48272FD0-98BF-42B4-A536-0B7E775B0D60Q41886077-A79948CF-D0AF-4345-BAA6-77854DE0A8FAQ42613711-0937DD78-68D1-424A-BAFC-59B94313A6DCQ42789116-B3658417-97C4-4F23-BE78-063053AF222FQ42858522-202B090E-8B6F-4FA7-BC9C-16542ADD4216
P2860
In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair
description
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1997
@ast
im Mai 1997 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1997/05/15)
@sk
vědecký článek publikovaný v roce 1997
@cs
wetenschappelijk artikel (gepubliceerd op 1997/05/15)
@nl
наукова стаття, опублікована в травні 1997
@uk
научни чланак (објављен 1997/05/15)
@sr
name
In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair
@ast
In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair
@en
In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair
@nl
type
label
In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair
@ast
In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair
@en
In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair
@nl
prefLabel
In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair
@ast
In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair
@en
In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair
@nl
P2093
P3181
P1433
P1476
In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair
@en
P2093
C. L. MacLeod
P. S. Norris
R. D. Christen
S. B. Howell
P304
P3181
P407
P577
1997-05-15T00:00:00Z